Gkika, E., Waller, C., Dejonckheere, C., Layer, J. P., Meiners, J., Schmidt, J., Brossart, P., Rodermann, E., Schiefer, A. S., Münter, M., Nicolay, N., Grosu, A., Rimner, A., Schmid, S. (2026). InDuRanS: A randomized phase II trial on induction immunochemotherapy followed by surgery or chemoradiotherapy and consolidation durvalumab in stage III NSCLC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps8125